Advertisement

Topics

Immunocore Limited Company Profile

23:33 EDT 23rd September 2018 | BioPortfolio

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located at Milton Park, near Oxford. The company traces its roots back to Avidex Limited which was founded in 1999 as a spin-out from the University of Oxford to develop technology invented by the founder and chief scientist, Dr Bent Jakobsen. Avidex was acquired in 2006 by the German company Medigene AG. In 2008, MediGene span out two independent companies based on the same core TCR enhancement technology platform; Immunocore to develop soluble protein therapeutics and Adaptimmune to develop cellular therapies. ( www.immunocore.com ).

Location

57c Milton Park
Abingdon
Oxford
Oxon
OX14 4RX
UK

Contact

Phone: +44 (0)1235 438600
Fax: +44 (0)1235 438601
Email: Info@immunocore.com


News Articles [50 Associated News Articles listed on BioPortfolio]

#jobs #lifescience Immunocore: Director, Market Access

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Immunocore: Director, Market Access . Immunocore: As part of our new Commerci...

Immunocore & Adaptimmune: Battling Cancer

James Noble, CEO of both Immunocore and Adaptimmune joined Fintan Walton at BioTrinity to talk through the separate business models the two companies have despite having been founded with the same pla...

#jobs #lifescience Immunocore: Senior Clinical Project Manager

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Immunocore: Senior Clinical Project Manager . Immunocore: We’re looking...

#jobs #lifescience Immunocore: Associate Director, Clinical Operations

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Immunocore: Associate Director, Clinical Operations . Immunocore: As the Asso...

Immunocore doses first patient in Phase I trial of IMCnyeso

Immunocore has dosed the first patient in a Phase I trial to investigate the safety and tolerability of IMCnyeso for...Read More... The post Immunocore doses first patient in Phase I trial of IMCnyeso...

Immunocore initiates phase 1 study of IMCnyeso in patients with solid tumors

The study, the first programme under Immunocore’s collaboration with GSK to proceed into clinical development, will assess the safety and tolerability of IMCnyeso in patients with non-small cell Th...

Interview: Immunocore Gets Ready To Go To Market

The first molecule from its collaboration with GSK has just gone into Phase I trials but Immunocore CEO Andrew Hotchkiss...   

Genentech, Kevin Sin: Harnessing the power of the body to fight cancer

In this interview, filmed at BIO Europe in Vienna, Paul Larsmon talks to Kevin Sin, Director, Business Development, Oncology at Genentech about their collaborations with Immunocore for the discovery ...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [83 Associated Companies listed on BioPortfolio]

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Adaptimmune Limited

Adaptimmune Limited is focused on the use of T cell therapy to treat HIV and cancer. It aims to utilize the body’s own machinery – the T lymphocyte cell – to target and destroy can...

SIEMENS CANADA LIMITED

VASUDHA PHARMA CHEM LIMITED

VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

More Information about "Immunocore Limited" on BioPortfolio

We have published hundreds of Immunocore Limited news stories on BioPortfolio along with dozens of Immunocore Limited Clinical Trials and PubMed Articles about Immunocore Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Immunocore Limited Companies in our database. You can also find out about relevant Immunocore Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record